Literature DB >> 26744362

Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.

Yuichi Tasaka1,2, Daiki Yasunaga1,2, Mamoru Tanaka1,2,3, Akihiro Tanaka4,5,6, Takashige Asakawa2,3, Ikuo Horio3, Yoshiro Miyauchi3, Hiroaki Araki1,2.   

Abstract

BACKGROUND: Pharmaceutical interventions by community and hospital pharmacists can improve medication safety and result in financial savings. Their effect has not been fully explored in Japan.
OBJECTIVE: To evaluate the economic and safety contributions of various pharmaceutical interventions by community and hospital pharmacists in Japan.
SETTING: Two hospitals and eight community pharmacies in Ehime Prefecture, Japan, in 2014-2015.
METHOD: Pharmacists entered data about pharmaceutical interventions via the internet, and the data were divided into 11 types of interventions. The economic impact was estimated based on the rate of avoidance of serious adverse drug reactions and the monetary cost of these reactions in the Japanese compensation system. The cost saving from adjusting prescriptions to take account of unused prescription drugs was calculated using drug prices from the national health insurance scheme. Main OUTCOME MEASURE: The number of pharmaceutical interventions and their economic impact. RESULTS The total cost savings from 500 to 509 pharmaceutical interventions by community and hospital pharmacists were US$207,126.6 and US$592,840, respectively. Community pharmacists mainly intervened to correct prescription errors. They also adjusted 135 prescriptions to take account of unused prescription drugs. This potentially improved patients' adherence and contributed to effective use of medication. Pharmaceutical interventions by hospital pharmacists facilitated avoidance of 10 serious adverse drug reactions, and included 42 transvenous antimicrobial therapy interventions, 88 interventions in cancer chemotherapy, and 47 monitoring recommendations. Hospital pharmacists helped improve patients' quality of life using more aggressive interventions besides correcting prescription errors. Over half of pharmaceutical interventions by community and hospital pharmacists contributed to avoidance of adverse drug reactions.
CONCLUSION: These results suggest the importance of pharmaceutical interventions by both community and hospital pharmacists in reducing increasing medical expenses and contributing to safety and effectiveness of medication. They also suggest that community and hospital pharmacists have different roles.

Entities:  

Keywords:  Adverse drug reaction; Community pharmacist; Economic impact; Hospital pharmacist; Japan; Pharmaceutical intervention

Mesh:

Year:  2016        PMID: 26744362     DOI: 10.1007/s11096-015-0245-6

Source DB:  PubMed          Journal:  Int J Clin Pharm


  19 in total

Review 1.  Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.

Authors:  Michel Burnier
Journal:  Am J Hypertens       Date:  2006-11       Impact factor: 2.689

2.  Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.

Authors:  Peter J Zed; Riyad B Abu-Laban; Robert M Balen; Peter S Loewen; Corinne M Hohl; Jeffrey R Brubacher; Kerry Wilbur; Matthew O Wiens; Leslie J Samoy; Katie Lacaria; Roy A Purssell
Journal:  CMAJ       Date:  2008-06-03       Impact factor: 8.262

3.  Medication errors and adverse drug events in pediatric inpatients.

Authors:  R Kaushal; D W Bates; C Landrigan; K J McKenna; M D Clapp; F Federico; D A Goldmann
Journal:  JAMA       Date:  2001-04-25       Impact factor: 56.272

4.  Root Cause Analysis of Ambulatory Adverse Drug Events That Present to the Emergency Department.

Authors:  Sarah A Gertler; Zlatan Coralic; Andrea López; John C Stein; Urmimala Sarkar
Journal:  J Patient Saf       Date:  2016-09       Impact factor: 2.844

5.  Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle risk factor study 2004-2006.

Authors:  E D Janus; S J Bunker; A Kilkkinen; K Mc Namara; B Philpot; P Tideman; R Tirimacco; T K Laatikainen; S Heistaro; J A Dunbar
Journal:  Intern Med J       Date:  2008-02-14       Impact factor: 2.048

6.  Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab).

Authors:  Esther M Briganti; Jonathan E Shaw; Steven J Chadban; Paul Z Zimmet; Timothy A Welborn; John J McNeil; Robert C Atkins
Journal:  Med J Aust       Date:  2003-08-04       Impact factor: 7.738

7.  Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

Authors:  Bernard Vrijens; Gäbor Vincze; Paulus Kristanto; John Urquhart; Michel Burnier
Journal:  BMJ       Date:  2008-05-14

Review 8.  Medication-related emergency department visits and hospital admissions in pediatric patients: a qualitative systematic review.

Authors:  Peter J Zed; Christopher Haughn; Karen J L Black; Eleanor A Fitzpatrick; Stacy Ackroyd-Stolarz; Nancy G Murphy; Neil J MacKinnon; Janet A Curran; Doug Sinclair
Journal:  J Pediatr       Date:  2013-03-01       Impact factor: 4.406

9.  Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study.

Authors:  Chen Wu; Chaim M Bell; Walter P Wodchis
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

10.  Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization.

Authors:  Valentina Perrone; Valentino Conti; Mauro Venegoni; Stefania Scotto; Luca Degli Esposti; Diego Sangiorgi; Lucia Prestini; Sonia Radice; Emilio Clementi; Giuseppe Vighi
Journal:  Clinicoecon Outcomes Res       Date:  2014-12-03
View more
  3 in total

1.  The implementation of pharmaceutical services in public hospitals in Mexico: an analysis of the legal framework and organizational practice.

Authors:  Laura C Vargas López; Fela Viso Gurovich; Anahí Dreser Mansilla; Veronika J Wirtz; Michael R Reich
Journal:  J Pharm Policy Pract       Date:  2021-05-05

2.  Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan.

Authors:  Yuichi Tasaka; Akihiro Tanaka; Daiki Yasunaga; Takashige Asakawa; Hiroaki Araki; Mamoru Tanaka
Journal:  J Pharm Health Care Sci       Date:  2018-12-13

3.  Drug related problems in the neonatal intensive care unit: incidence, characterization and clinical relevance.

Authors:  Ramon Duarte Leopoldino; Marco Tavares Santos; Tatiana Xavier Costa; Rand Randall Martins; António Gouveia Oliveira
Journal:  BMC Pediatr       Date:  2019-04-26       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.